Lymphoma, T-Cell, Cutaneous - 27 Studies Found
Active, not recruiting |
: Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) : Cutaneous T Cell Lymphoma : 2012-07-15 :
|
Completed |
: Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma : Cutaneous T-Cell Lymphoma : 2006-03-23 :
|
Completed |
: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) : Cutaneous T-cell Lymphoma : 2005-03-24 : Drug: romidepsin (depsipeptide, FK228) Study patients received romidepsin at a dose of 14 mg/m^2 intrave |
Recruiting |
: Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) : Cutaneous T-Cell Lymphoma : 2015-10-29 : Biological: IPH4102 |
Recruiting |
: Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) : Cutaneous T Cell Lymphoma : 2015-09-06 : Drug: dimethylfumarate dose escalation from 30 mg/d to 720 mg/d over 9 weeks following a preset design i |
NOT_YET_RECRUITING |
: A Safety Study of SGN-35T in Adults With Advanced Cancers : Lymphoma, T-Cell, Cutaneous : 2024-05-21 : Given into the vein (IV; intravenously) |
RECRUITING |
: Tissue Repository: CTCL Collection Protocol : Lymphoma, T-Cell, Cutaneous : 2024-05-21 |